Research Knowledgebase

Genitourinary Malignancies Program

Program Leader(s)

For a list of all the program participants and related research, click here.

Description of Program

The Genitourinary Malignancies Program consists of outstanding scientists and physicians who are part of an innovative scientific team focused on studying cancers of the genital and urinary organs. This group of scientists have made it possible for the Cancer Center to develop this research area into a full-fledged program.

Goals of Program

The overriding goal of the Genitourinary Malignancies Program is to translate research from the bench to the bedside in the areas of prostate, bladder, and kidney cancers. Specific research goals include:

• Characterize the mechanisms behind novel therapeutic agents in complementary and alternative medicine.

• Explore new targeted therapeutic strategies that kill prostate cancer cells themselves and work in concert with radiation, hormone therapy and/or chemotherapy.

• Develop new markers that may be applied clinically for screening to identify the presence of cancer and for determining how best to treat an individual’s cancer once identified.

Research themes in this program currently include:

• Novel Therapeutic Agents/Targets

• Biomarkers/Functional Imaging

• Novel Therapeutic Techniques

Participants

Mansoor M. Ahmed, Ph.D.
Kerry L. Burnstein, Ph.D.
Ram H. Datar, Ph.D.
Jennifer J. Hu, Ph.D.
Balakrishna L. Lokeshwar, Ph.D.
Vinata B. Lokeshwar, Ph.D.
Zafar Nawaz, Ph.D.
Frank Penedo, Ph.D.
Andrew V. Schally, Ph.D., M.D.h.c., D.Sc.h.c.
Rakesh Singal, M.D.
Mark S. Soloway, M.D.

Back to Research Knowledgebase